Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 701 (USA) (Dr. Reyes)
· consented 2013-01-05
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-19 (study day 15.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-26 (study day 22.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-01-26 (study day 22.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-19 (study day 15.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-01-26 (study day 22.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.